|
市場調査レポート
商品コード
1796910
自己血糖測定市場:世界の産業規模・シェア・動向・機会・予測 (製品別、用途別、エンドユーザー別、地域別)、競合情勢 (2020~2030年)Self-monitoring Blood Glucose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region and Competition, 2020-2030F |
||||||
カスタマイズ可能
|
|||||||
| 自己血糖測定市場:世界の産業規模・シェア・動向・機会・予測 (製品別、用途別、エンドユーザー別、地域別)、競合情勢 (2020~2030年) |
|
出版日: 2025年08月25日
発行: TechSci Research
ページ情報: 英文 188 Pages
納期: 2~3営業日
|
全表示
- 概要
- 目次
世界の自己血糖測定の市場規模は2024年に102億8,000万米ドル、予測期間中のCAGRは8.61%で2030年には168億7,000万米ドルに達すると予測されています。
血糖モニタリングは、糖尿病患者が食事摂取量、インスリン投与量、運動量に関して、十分な情報に基づいた日常管理の意思決定を行う上で重要な役割を果たしています。自己血糖測定(SMBG)は、患者が血糖値を迅速にチェックし、毛細血管グルコース濃度の正確な測定値を得るために血糖測定器を使用することを伴う、現代的な糖尿病管理手順です。検査ストリップ、ランセット、血糖測定器を含むSMBG技術は、長期的な血糖コントロールを促進します。測定値を分析することで、治療を調整し、抗糖尿病薬やストレス管理の影響を評価し、食事、インスリン投与量、身体運動などに関して、十分な情報に基づいた決定を下すことができます。この包括的なプロセスには、持続的な血糖コントロールを達成するための検査ストリップ、ランセット、血糖測定器の利用が含まれます。
| 市場概要 | |
|---|---|
| 予測期間 | 2026-2030 |
| 市場規模:2024年 | 102億8,000万米ドル |
| 市場規模:2030年 | 168億7,000万米ドル |
| CAGR:2025年~2030年 | 8.61% |
| 急成長セグメント | 2型糖尿病 |
| 最大市場 | 北米 |
市場促進要因
糖尿病の高い有病率
主な市場課題
コンプライアンスとアドヒアランス
主要市場動向
市場における新製品の発売
目次
第1章 イントロダクション
第2章 分析手法
第3章 エグゼクティブサマリー
第4章 顧客の声
第5章 世界の自己血糖測定市場の展望
- 市場規模・予測
- 金額ベース
- 市場シェア・予測
- 製品別(自己血糖測定器、持続的血糖モニター、検査用試験紙、ランセット)
- 用途別(1型糖尿病、2型糖尿病、妊娠糖尿病)
- エンドユーザー別(病院、在宅医療、診断センター)
- 地域別
- 企業別(2024年)
- 市場マップ
第6章 北米の自己血糖測定市場の展望
- 市場規模・予測
- 市場シェア・予測
- 北米:国別分析
- 米国
- カナダ
- メキシコ
第7章 欧州の自己血糖測定市場の展望
- 市場規模・予測
- 市場シェア・予測
- 欧州:国別分析
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
第8章 アジア太平洋の自己血糖測定市場の展望
- 市場規模・予測
- 市場シェア・予測
- アジア太平洋:国別分析
- 中国
- インド
- 日本
- 韓国
- オーストラリア
第9章 南米の自己血糖測定市場の展望
- 市場規模・予測
- 市場シェア・予測
- 南米:国別分析
- ブラジル
- アルゼンチン
- コロンビア
第10章 中東・アフリカの自己血糖測定市場の展望
- 市場規模・予測
- 市場シェア・予測
- 中東・アフリカ:国別分析
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
第11章 市場力学
- 促進要因
- 課題
第12章 市場動向と発展
第13章 世界の自己血糖測定市場:SWOT分析
第14章 競合情勢
- Abbott Laboratories
- Medtronic plc
- F. Hoffmann-La Roche Ltd
- Ascensia Diabetes Care
- Dexcom, Inc.
- Sanofi
- Novo Nordisk
- Insulet Corporation
- Ypsomed Holdings
- Glysens Incorporated
第15章 戦略的提言
第16章 調査会社について・免責事項
Global Self-monitoring Blood Glucose Market has valued at USD 10.28 Billion in 2024 and is expected to reach USD 16.87 billion by 2030 with a CAGR of 8.61% during the forecast period. Blood glucose monitoring plays a crucial role in empowering diabetic patients to make informed daily management decisions regarding food intake, insulin dosage and physical exercise. Self-monitoring blood glucose (SMBG) represents a contemporary diabetes management procedure that entails the use of blood glucose meters by patients to quickly check their glucose levels and obtain accurate measurements of capillary glucose concentration. SMBG technology, encompassing test strips, lancets, and blood glucose meters, facilitates long-term glycemic control. By analyzing readings, individuals can adjust treatment, evaluate the impact of antidiabetics and stress management, and make informed decisions regarding diet, insulin dosage, and physical exercise, among other factors. This comprehensive process involves the utilization of test strips, lancets, and blood glucose meters to achieve sustained glycemic control.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 10.28 Billion |
| Market Size 2030 | USD 16.87 Billion |
| CAGR 2025-2030 | 8.61% |
| Fastest Growing Segment | Type 2 Diabetes |
| Largest Market | North America |
Key Market Drivers
High Prevalence of Diabetes
The increase in the geriatric population and the high prevalence of diabetes, along with the rising risk factors associated with diabetes, are key drivers for the growth of the self-monitoring of blood glucose (SMBG) market. Furthermore, government initiatives aimed at raising awareness among the population also contribute to the market's growth. However, it should be noted that the devices do not measure the exact level of glucose in the blood, which can result in inaccurate results. Moreover, the lack of reimbursement and stringent regulations for these devices may hinder the overall market growth. Nevertheless, there are untapped opportunities in emerging markets, and the growing awareness about diabetes monitoring devices is expected to generate new prospects within the forecast period. However, challenges such as the lack of patient awareness and the high cost of advanced devices and accessories are projected to impede the market's growth.
Key Market Challenges
Compliance and Adherence
Regular and consistent blood glucose monitoring is essential for effective diabetes management. However, some individuals may struggle with adherence, either due to forgetfulness, discomfort associated with testing, or a lack of motivation. Properly using self-monitoring blood glucose devices requires some level of technical skill and knowledge. Some elderly individuals or those with limited dexterity may find it challenging to operate the devices correctly. Self-monitoring blood glucose devices need to be accurately calibrated and maintained to provide reliable results. Incorrect calibration or using expired test strips can lead to inaccurate readings.
Key Market Trends
New Product Launches in the Market
Prominent companies operating in the self-monitoring blood glucose (SMBG) devices market are strategically focused on developing innovative technological solutions to enhance their market position. For instance, in August 2022, Intuity Medical, Inc., a commercial-stage medical technology and digital health company committed to simplifying life with diabetes, introduced the POGO Automatic(R) Blood Glucose Monitoring System at over 2,200 US pharmacies operated by Kroger Health, the healthcare division of The Kroger Co. The POGO Automatic from Intuity Medical is the sole FDA-approved automatic blood glucose monitor featuring 10-test cartridge technology, eliminating the need for individuals with diabetes to carry or load separate lancets and test strips. It effortlessly lances, collects blood, and provides a glucose result with just a touch of a button.
Key Market Players
- Abbott Laboratories
- Medtronic plc
- F. Hoffmann-La Roche Ltd
- Ascensia Diabetes Care
- Dexcom, Inc.
- Sanofi
- Novo Nordisk
- Insulet Corporation
- Ypsomed Holdings
- Glysens Incorporated
Report Scope:
In this report, the Global Self-monitoring Blood Glucose Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Self-monitoring Blood Glucose Market, By Product:
- Self-monitoring Blood Glucose Meters
- Continuous Glucose Monitors
- Testing Strips
- Lancets
Self-monitoring Blood Glucose Market, By Application:
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
Self-monitoring Blood Glucose Market, By End User:
- Hospitals
- Home Settings,
- Diagnostic Centers
Self-monitoring Blood Glucose Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Self-monitoring Blood Glucose Market.
Available Customizations:
Global Self-monitoring Blood Glucose market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Self-monitoring Blood Glucose Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets)
- 5.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
- 5.2.3. By End User (Hospitals, Home Settings, and Diagnostic Centres)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
- 5.3. Market Map
6. North America Self-monitoring Blood Glucose Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Application
- 6.2.3. By End User
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Self-monitoring Blood Glucose Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Product
- 6.3.1.2.2. By Application
- 6.3.1.2.3. By End User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Self-monitoring Blood Glucose Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Product
- 6.3.2.2.2. By Application
- 6.3.2.2.3. By End User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Self-monitoring Blood Glucose Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Product
- 6.3.3.2.2. By Application
- 6.3.3.2.3. By End User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Self-monitoring Blood Glucose Market Outlook
7. Europe Self-monitoring Blood Glucose Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Self-monitoring Blood Glucose Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. United Kingdom Self-monitoring Blood Glucose Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. Italy Self-monitoring Blood Glucose Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. France Self-monitoring Blood Glucose Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product
- 7.3.4.2.2. By Application
- 7.3.4.2.3. By End User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Self-monitoring Blood Glucose Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product
- 7.3.5.2.2. By Application
- 7.3.5.2.3. By End User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Self-monitoring Blood Glucose Market Outlook
8. Asia-Pacific Self-monitoring Blood Glucose Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Self-monitoring Blood Glucose Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Self-monitoring Blood Glucose Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Self-monitoring Blood Glucose Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Self-monitoring Blood Glucose Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Self-monitoring Blood Glucose Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Self-monitoring Blood Glucose Market Outlook
9. South America Self-monitoring Blood Glucose Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Self-monitoring Blood Glucose Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Self-monitoring Blood Glucose Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Self-monitoring Blood Glucose Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Self-monitoring Blood Glucose Market Outlook
10. Middle East and Africa Self-monitoring Blood Glucose Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Self-monitoring Blood Glucose Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Self-monitoring Blood Glucose Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Self-monitoring Blood Glucose Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Self-monitoring Blood Glucose Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
13. Global Self-monitoring Blood Glucose Market: SWOT Analysis
14. Competitive Landscape
- 14.1. Abbott Laboratories
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
- 14.2. Medtronic plc
- 14.3. F. Hoffmann-La Roche Ltd
- 14.4. Ascensia Diabetes Care
- 14.5. Dexcom, Inc.
- 14.6. Sanofi
- 14.7. Novo Nordisk
- 14.8. Insulet Corporation
- 14.9. Ypsomed Holdings
- 14.10. Glysens Incorporated
